G protein-coupled receptor connectivity to NF-kappaB in inflammation and cancer (Q37293340)

19 August 2017

1 reference

title

G protein-coupled receptor connectivity to NF-kappaB in inflammation and cancer (English)

1 reference

G protein-coupled receptor

19 August 2017

0 references

0 references

1 reference

Christopher C Fraser

1

1 reference

19 August 2017

1 January 2008

1 reference

International Reviews of Immunology

19 August 2017

1 reference

19 August 2017

27

1 reference

19 August 2017

5

1 reference

19 August 2017

320-350

1 reference

Circuitry of nuclear factor kappaB signaling

19 August 2017

1 reference

https://api.crossref.org/works/10.1080%2F08830180802262765

The two NF-kappaB activation pathways and their role in innate and adaptive immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08830180802262765

Shared principles in NF-kappaB signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08830180802262765

Integrating cell-signalling pathways with NF-kappaB and IKK function

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08830180802262765

Transcriptional regulation via the NF-kappaB signaling module.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08830180802262765

Tripping the switch fantastic: how a protein kinase cascade can convert graded inputs into switch-like outputs

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08830180802262765

Nuclear factor-kappaB: a pivotal transcription factor in chronic inflammatory diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08830180802262765

Therapeutic potential of inhibition of the NF-kappaB pathway in the treatment of inflammation and cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08830180802262765

Nuclear factor-kappaB inhibitors as sensitizers to anticancer drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08830180802262765

Nuclear factor-kappaB: the enemy within

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08830180802262765

Inflammation-associated cancer: NF-kappaB is the lynchpin

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08830180802262765

NF-kappaB: linking inflammation and immunity to cancer development and progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08830180802262765

IKK/NF-kappaB signaling: balancing life and death--a new approach to cancer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08830180802262765

Inhibitors of NF-kappaB signaling: 785 and counting

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08830180802262765

The IKK NF-kappa B system: a treasure trove for drug development

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08830180802262765

21 January 2018

Signaling to NF-kappaB

1 reference

https://api.crossref.org/works/10.1080%2F08830180802262765

The G protein-coupled receptor subset of the rat genome

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08830180802262765

The G-protein-coupled receptors in the human genome form five main families. Phylogenetic analysis, paralogon groups, and fingerprints

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08830180802262765

Structural diversity of G protein-coupled receptors and significance for drug discovery

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08830180802262765

G-protein-coupled receptor expression, function, and signaling in macrophages

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08830180802262765

Chemokines in rheumatic diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08830180802262765

G-protein-coupled receptors and cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08830180802262765

Roles of G-protein-coupled receptor signaling in cancer biology and gene transcription

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08830180802262765

Role of chemokines in tumor growth

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08830180802262765

Innate immunity gone awry: linking microbial infections to chronic inflammation and cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08830180802262765

Prostaglandin E receptor type 4-associated protein interacts directly with NF-kappaB1 and attenuates macrophage activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08830180802262765

CARD-Bcl10-Malt1 signalosomes: missing link to NF-kappaB.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08830180802262765

The melanocortin system in leukocyte biology

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08830180802262765

Bcl10 and Malt1 control lysophosphatidic acid-induced NF-kappaB activation and cytokine production

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08830180802262765

Lipoteichoic acid-induced nitric oxide production depends on the activation of platelet-activating factor receptor and Jak2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08830180802262765

Beta-agonists modulate T-cell functions via direct actions on type 1 and type 2 cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08830180802262765

Mitogenic signaling pathways induced by G protein-coupled receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08830180802262765

Targeting the protein kinase C family: are we there yet?

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08830180802262765

Protein kinase C and other diacylglycerol effectors in cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08830180802262765

Protein kinase A (PKA)--a potential target for therapeutic intervention of dysfunctional immune cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08830180802262765

Localized effects of cAMP mediated by distinct routes of protein kinase A.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08830180802262765

Cell physiology of cAMP sensor Epac

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08830180802262765

Classical PKC isoforms in cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08830180802262765

Protein kinase C theta (PKCtheta): a key player in T cell life and death

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08830180802262765

Protein kinase C: a target for therapy in pancreatic cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08830180802262765

Phorbol ester up-regulates phospholipase D1 but not phospholipase D2 expression through a PKC/Ras/ERK/NFkappaB-dependent pathway and enhances matrix metalloproteinase-9 secretion in colon cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08830180802262765

Sustained activation of protein kinase C downregulates nuclear factor-kappaB signaling by dissociation of IKK-gamma and Hsp90 complex in human colonic epithelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08830180802262765

Activation of IKK by thymosin alpha1 requires the TRAF6 signalling pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08830180802262765

Tumour-suppression activity of the proapoptotic regulator Par4.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08830180802262765

CXCR2 ligands and G-CSF mediate PKCalpha-induced intraepidermal inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08830180802262765

Induction of colitis causes inflammatory responses in fat depots: evidence for substance P pathways in human mesenteric preadipocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08830180802262765

Targeted disruption of the zetaPKC gene results in the impairment of the NF-kappaB pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08830180802262765

Essential role of RelA Ser311 phosphorylation by zetaPKC in NF-kappaB transcriptional activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08830180802262765

The CARMA1 signalosome links the signalling machinery of adaptive and innate immunity in lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08830180802262765

CARMA3/Bcl10/MALT1-dependent NF-kappaB activation mediates angiotensin II-responsive inflammatory signaling in nonimmune cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08830180802262765

CARMA3 deficiency abrogates G protein-coupled receptor-induced NF-{kappa}B activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08830180802262765

Bcl10 plays a critical role in NF-kappaB activation induced by G protein-coupled receptors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08830180802262765

Protein kinase C alpha-CARMA3 signaling axis links Ras to NF-kappa B for lysophosphatidic acid-induced urokinase plasminogen activator expression in ovarian cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08830180802262765

Signaling crossroads: the function of Raf kinase inhibitory protein in cancer, the central nervous system and reproduction

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08830180802262765

Human phosphatidylethanolamine-binding protein facilitates heterotrimeric G protein-dependent signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08830180802262765

Protein kinase C switches the Raf kinase inhibitor from Raf-1 to GRK-2

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08830180802262765

Raf kinase inhibitor protein interacts with NF-kappaB-inducing kinase and TAK1 and inhibits NF-kappaB activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08830180802262765

Activation of Syk by protein kinase C-delta regulates thrombin-induced intercellular adhesion molecule-1 expression in endothelial cells via tyrosine phosphorylation of RelA/p65.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08830180802262765

PDK1 nucleates T cell receptor-induced signaling complex for NF-kappaB activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08830180802262765

Phosphorylation of the CARMA1 linker controls NF-kappaB activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08830180802262765

Phosphorylation of CARMA1 plays a critical role in T Cell receptor-mediated NF-kappaB activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08830180802262765

PKC beta regulates BCR-mediated IKK activation by facilitating the interaction between TAK1 and CARMA1

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08830180802262765

IkappaB kinase beta-induced phosphorylation of CARMA1 contributes to CARMA1 Bcl10 MALT1 complex formation in B cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08830180802262765

Protein kinase C theta affects Ca2+ mobilization and NFAT cell activation in primary mouse T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08830180802262765

Control of lymphocyte development by nuclear factor-kappaB.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08830180802262765

PKC-theta-deficient mice are protected from Th1-dependent antigen-induced arthritis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08830180802262765

Protein kinase C theta plays a fundamental role in different types of chronic colitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08830180802262765

Mouse mammary tumor virus c-rel transgenic mice develop mammary tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08830180802262765

Aberrant nuclear factor-kappaB/Rel expression and the pathogenesis of breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08830180802262765

Aberrant rel/nfkb genes and activity in human cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08830180802262765

Inhibitors of protein kinase C (PKC) prevent activated transcription: role of events downstream of NF-kappaB DNA binding

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08830180802262765

Curcumin decreases 12-O-tetradecanoylphorbol-13-acetate-induced protein kinase C translocation to modulate downstream targets in mouse skin

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08830180802262765

PKCdelta-mediated regulation of FLIP expression in human colon cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08830180802262765

Schedule-dependent molecular effects of the proteasome inhibitor bortezomib and gemcitabine in pancreatic cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08830180802262765

PKC412 demonstrates JNK-dependent activity against human multiple myeloma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08830180802262765

Isoforms of mammalian adenylyl cyclase: multiplicities of signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08830180802262765

Cyclic nucleotide phosphodiesterases: molecular regulation to clinical use

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08830180802262765

Phosphodiesterase-4: selective and dual-specificity inhibitors for the therapy of chronic obstructive pulmonary disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08830180802262765

Life after PDE4: overcoming adverse events with dual-specificity phosphodiesterase inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08830180802262765

Cyclic AMP-specific PDE4 phosphodiesterases as critical components of cyclic AMP signaling.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08830180802262765

Sildenafil: from angina to erectile dysfunction to pulmonary hypertension and beyond.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08830180802262765

A new phospholipase-C-calcium signalling pathway mediated by cyclic AMP and a Rap GTPase

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08830180802262765

The transcriptional activity of NF-kappaB is regulated by the IkappaB-associated PKAc subunit through a cyclic AMP-independent mechanism

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08830180802262765

Signaling pathways and genes that inhibit pathogen-induced macrophage apoptosis--CREB and NF-kappaB as key regulators

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08830180802262765

The role of protein kinase A and A-kinase anchoring proteins in modulating T-cell activation: progress and future directions

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08830180802262765

Negative regulation of T-cell receptor activation by the cAMP-PKA-Csk signalling pathway in T-cell lipid rafts

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08830180802262765

Inhibition of T cell activation by cyclic adenosine 5'-monophosphate requires lipid raft targeting of protein kinase A type I by the A-kinase anchoring protein ezrin

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08830180802262765

Mechanisms of deficient type I protein kinase A activity in lupus T lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08830180802262765

Protein kinase A as target for novel integrated strategies of cancer therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08830180802262765

Tumor reversion: protein kinase A isozyme switching

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08830180802262765

Transcription factors as therapeutic targets in lymphoid malignancies

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08830180802262765

NF-kappaB in pathogenesis and treatment of adult T-cell leukemia/lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08830180802262765

Nuclear factor kB as a target for new drug development in myeloid malignancies

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08830180802262765

The cAMP signaling pathway as a therapeutic target in lymphoid malignancies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08830180802262765

Phosphodiesterase inhibitors as anti-cancer drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08830180802262765

Cyclic nucleotide phosphodiesterases as targets for treatment of haematological malignancies

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08830180802262765

Adenosine, through the A1 receptor, inhibits vesicular MHC class I cross-presentation by resting DC.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08830180802262765

Adenosine and lymphocyte regulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08830180802262765

Suppression of leukotriene B4 biosynthesis by endogenous adenosine in ligand-activated human neutrophils

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08830180802262765

Adenosine is a negative regulator of NF-kappaB and MAPK signaling in human intestinal epithelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08830180802262765

The PI3K-NF-kappaB signal transduction pathway is involved in mediating the anti-inflammatory effect of IB-MECA in adjuvant-induced arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08830180802262765

Antiinflammatory adaptation to hypoxia through adenosine-mediated cullin-1 deneddylation

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08830180802262765

The anti-inflammatory effect of A3 adenosine receptor agonists: a novel targeted therapy for rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08830180802262765

Activation of Th1 and Tc1 cell adenosine A2A receptors directly inhibits IL-2 secretion in vitro and IL-2-driven expansion in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08830180802262765

Adenosine A2A agonists in development for the treatment of inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08830180802262765

Cutting edge: Physiologic attenuation of proinflammatory transcription by the Gs protein-coupled A2A adenosine receptor in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08830180802262765

Adenosine and cAMP are potent inhibitors of the NF-kappa B pathway downstream of immunoreceptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08830180802262765

A2A adenosine receptors on bone marrow-derived cells protect liver from ischemia-reperfusion injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08830180802262765

Synergistic up-regulation of vascular endothelial growth factor (VEGF) expression in macrophages by adenosine A2A receptor agonists and endotoxin involves transcriptional regulation via the hypoxia response element in the VEGF promoter

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08830180802262765

New insights into the regulation of inflammation by adenosine

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08830180802262765

Metabolic consequences of adenosine deaminase deficiency in mice are associated with defects in alveogenesis, pulmonary inflammation, and airway obstruction

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08830180802262765

Role of A2B adenosine receptor signaling in adenosine-dependent pulmonary inflammation and injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08830180802262765

The Quintiles Prize Lecture 2004. The identification of the adenosine A2B receptor as a novel therapeutic target in asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08830180802262765

cAMP-induced degradation of cyclin D3 through association with GSK-3beta

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08830180802262765

cAMP-dependent protein kinase regulates ubiquitin-proteasome-mediated degradation and subcellular localization of the nuclear receptor coactivator GRIP1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08830180802262765

Proteasome function is regulated by cyclic AMP-dependent protein kinase through phosphorylation of Rpt6

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08830180802262765

Compounds that increase or mimic cyclic adenosine monophosphate enhance tristetraprolin degradation in lipopolysaccharide-treated murine j774 macrophages

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08830180802262765

Activation of the adenosine A3 receptor in RAW 264.7 cells inhibits lipopolysaccharide-stimulated tumor necrosis factor-alpha release by reducing calcium-dependent activation of nuclear factor-kappaB and extracellular signal-regulated kinase 1/2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08830180802262765

Activation of adenosine A3 receptor suppresses lipopolysaccharide-induced TNF-alpha production through inhibition of PI 3-kinase/Akt and NF-kappaB activation in murine BV2 microglial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08830180802262765

Adenosine receptors as therapeutic targets

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08830180802262765

Adenosine suppresses activation of nuclear factor-kappaB selectively induced by tumor necrosis factor in different cell types

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08830180802262765

A3 adenosine receptor as a target for cancer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08830180802262765

The A3 adenosine receptor is highly expressed in tumor versus normal cells: potential target for tumor growth inhibition

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08830180802262765

Inhibition of primary colon carcinoma growth and liver metastasis by the A3 adenosine receptor agonist CF101

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08830180802262765

An agonist to the A3 adenosine receptor inhibits colon carcinoma growth in mice via modulation of GSK-3 beta and NF-kappa B.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08830180802262765

CF101, an agonist to the A3 adenosine receptor, enhances the chemotherapeutic effect of 5-fluorouracil in a colon carcinoma murine model

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08830180802262765

Signal transduction pathways regulating cyclooxygenase-2 expression: potential molecular targets for chemoprevention

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08830180802262765

Mechanisms leading to COX-2 expression and COX-2 induced tumorigenesis: topical therapeutic strategies targeting COX-2 expression and activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08830180802262765

Efficacy of the newest COX-2 selective inhibitors in rheumatic disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08830180802262765

Celecoxib: a review of its use in the management of arthritis and acute pain

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08830180802262765

Inflammation and breast cancer. Cyclooxygenase/prostaglandin signaling and breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08830180802262765

Cyclooxygenase-2 (COX-2): a molecular target in prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08830180802262765

Cyclooxygenase-2 in cervical neoplasia: a review

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08830180802262765

Prostaglandin E receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08830180802262765

Prostaglandin E2 and other cyclic AMP elevating agents inhibit interleukin 2 gene transcription by counteracting calcineurin-dependent pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08830180802262765

Prostaglandin-E2 is a potent inhibitor of human interleukin 12 production

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08830180802262765

Prostaglandin E2 is a potent regulator of interleukin-12- and interleukin-18-induced natural killer cell interferon-gamma synthesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08830180802262765

Prostaglandin E2 inhibits production of the inflammatory chemokines CCL3 and CCL4 in dendritic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08830180802262765

Interleukin-1beta-induced mucin production in human airway epithelium is mediated by cyclooxygenase-2, prostaglandin E2 receptors, and cyclic AMP-protein kinase A signaling.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08830180802262765

CXCL1 induced by prostaglandin E2 promotes angiogenesis in colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08830180802262765

Multiple regulatory elements in the interleukin-6 gene mediate induction by prostaglandins, cyclic AMP, and lipopolysaccharide.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08830180802262765

Toll-like receptors: from the discovery of NFkappaB to new insights into transcriptional regulations in innate immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08830180802262765

A ride on the ferrous wheel.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08830180802262765

Roles of prostanoids in colon carcinogenesis and their potential targeting for cancer chemoprevention.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08830180802262765

Nonsteroidal Anti-inflammatory Drugs and Cyclooxygenase-2 Inhibitors for Primary Prevention of Colorectal Cancer: A Systematic Review Prepared for the U.S. Preventive Services Task Force

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08830180802262765

Exploring the positive and negative consequences of NF-kappaB inhibition for the treatment of human disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08830180802262765

At the crossroads of inflammation and cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08830180802262765

Autonomic innervation and regulation of the immune system (1987-2007)

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08830180802262765

Role of nonsynaptic communication in regulating the immune response.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08830180802262765

It takes nerve to tell T and B cells what to do.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08830180802262765

Beta2-adrenergic receptor regulates Toll-like receptor-4-induced nuclear factor-kappaB activation through beta-arrestin 2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08830180802262765

beta2-Adrenoceptor agonists, like glucocorticoids, repress eotaxin gene transcription by selective inhibition of histone H4 acetylation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08830180802262765

Effect of inhaled formoterol and budesonide on exacerbations of asthma. Formoterol and Corticosteroids Establishing Therapy (FACET) International Study Group.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08830180802262765

Meta-analysis of increased dose of inhaled steroid or addition of salmeterol in symptomatic asthma (MIASMA).

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08830180802262765

Human CD4+CD25+ regulatory T cells selectively express tyrosine hydroxylase and contain endogenous catecholamines subserving an autocrine/paracrine inhibitory functional loop.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08830180802262765

Dobutamine inhibits phorbol-myristate-acetate-induced activation of nuclear factor-kappaB in human T lymphocytes in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08830180802262765

Neurotransmitters and chemokines regulate tumor cell migration: potential for a new pharmacological approach to inhibit invasion and metastasis development

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08830180802262765

Neurotransmitter receptor-mediated signaling pathways as modulators of carcinogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08830180802262765

Epinephrine protects cancer cells from apoptosis via activation of cAMP-dependent protein kinase and BAD phosphorylation

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08830180802262765

Norepinephrine up-regulates the expression of vascular endothelial growth factor, matrix metalloproteinase (MMP)-2, and MMP-9 in nasopharyngeal carcinoma tumor cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08830180802262765

Neuroendocrine modulation of signal transducer and activator of transcription-3 in ovarian cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08830180802262765

The role of alpha-blockers in the management of prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08830180802262765

The alpha1-adrenergic receptor antagonist doxazosin inhibits EGFR and NF-kappaB signalling to induce breast cancer cell apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08830180802262765

Epidermal growth factor-induced esophageal cancer cell proliferation requires transactivation of beta-adrenoceptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08830180802262765

PKC-θ is required for TCR-induced NF-κB activation in mature but not immature T lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08830180802262765

10.1080/08830180802262765

21 January 2018

Identifiers

DOI

1 reference

19 August 2017

1 reference

PubMed ID

18853342